Amylyx Overview
- Founded
- 2013

- Status
- Public
- Employees
- 205

- Stock Symbol
- AMLX

- Share Price
- $8.74
- (As of Wednesday Closing)
Amylyx General Information
Description
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Contact Information
- 43 Thorndike Street
- Cambridge, MA 02141
- United States
Amylyx Timeline
Amylyx Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$8.74 | $8.78 | $6.51 - $33.41 | $512M | 58.5M | 798K | -$2.53 |
Amylyx Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 886,788 | |||
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (121,198) | (87,915) | (40,005) | (12,616) |
Net Income | (121,256) | (87,931) | (42,280) | (13,716) |
Total Assets | 274,438 | 105,614 | 14,104 | 3,220 |
Total Debt | 7,191 | 0 | 1,425 | 14,931 |
Amylyx Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Amylyx‘s full profile, request access.
Request a free trialAmylyx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Amylyx‘s full profile, request access.
Request a free trialAmylyx Comparisons
Industry
00000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAmylyx Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Aquinnah | Venture Capital-Backed | Cambridge, MA | 0 | 0000 | 0000000000 | 0000 |
0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00.000 | 0000 | 00.000 |
0000000 | Formerly VC-backed | Boston, MA | 0000 | 000000&0 | ||
000000000 | Formerly VC-backed | Copenhagen, Denmark | 000 | 00000 | 000000&0 | |
000000000 00000000 | Formerly VC-backed | New York, NY | 00 | 000.00 | 00000000 | 000.00 |
Amylyx Patents
Amylyx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210186990-A1 | Methods and compositions for treating various disorders | Pending | 16-Dec-2019 | 000000000 | |
US-20210177867-A1 | Compositions of bile acids and phenylbutyrate compounds | Pending | 16-Dec-2019 | 000000000 |
Amylyx Executive Team (10)
Amylyx Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Alan Walts Ph.D | Self | Board Observer | 000 0000 |
Daphne Quimi | Self | Board Member | 000 0000 |
Daphne Quimi | Amylyx | Board Member | 000 0000 |
Felix von Coerper | ALS Investment Fund | Board Member | 000 0000 |
George Milne Ph.D | Self | Chairman & Board Member | 000 0000 |
Amylyx Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmylyx Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Amylyx‘s full profile, request access.
Request a free trial